Tissue Repository: CTCL Collection Protocol
Part of paid clinical trials in New York, New York.
- Sponsor
- Columbia University
- Study ID
- NCT02840747
- Status
- Recruiting
Conditions
- Lymphoma, T-Cell, Cutaneous
- Lymphomatoid Papulosis
- Sézary Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
This document is a protocol for a non-interventional human research study in which the investigator hopes to better understand the changes that take place in T cells in Cutaneous T-cell lymphoma (CTCL). The purpose of this study is to establish a protocol for the collection and storage of tissue samples from patients with CTCL for future research studies. Collection and storage of tissue samples from control patients will also be carried out.
Key Dates
- Start date
- Jul 31, 2016
- Status verified
- Nov 2025
- Primary completion
- Oct 31, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: Patients with CTCLSkin biopsies, blood samples, skin swabs, nasal swabs, cheek epithelium swabs, fecal samples and urine samples may be collected from patients with CTCL (according to World Health Organization-European Organization for Research and Treatment of Cancer (WHO-EORTC) criteria).
- Arm: Patients with benign dermatosesSkin biopsies, blood samples, skin swabs, nasal swabs, cheek epithelium swabs, fecal samples and urine samples may be collected from patients with benign dermatoses, including but not limited to conditions such as eczema, psoriasis, and dermatitis.
- Arm: Healthy ControlsSkin biopsies, blood samples, skin swabs, nasal swabs, cheek epithelium swabs, fecal samples and urine samples may be collected from healthy volunteers.
Primary Outcome Measure
Number of biological specimen collections [ Time Frame: 2 years ]
Central Contacts
- Larisa J. Geskin, MD
- Brigit Lapolla
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10032 | Brigit Lapolla Larisa J. Geskin, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site
Related Studies
- Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Stanford, California
- Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid PapulosisRecruiting · M.D. Anderson Cancer Center · Houston, Texas